查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886278

轉染技術市場－全球產業規模、佔有率、趨勢、機會和預測，按轉染方法、產品、應用、技術、地區和競爭格局分類，2020-2030年預測

Transfection Technologies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Transfection Method, By Product, By Applications, By Technology, By Region, and By Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球轉染技術市場規模為30.3億美元，預計2030年將以9.61%的複合年成長率成長至52.5億美元。轉染技術涵蓋將外源核酸（例如DNA或RNA）導入真核細胞的方法，從而實現基因改造，應用於各種研究、治療和生物生產領域。該市場的成長主要受全球生命科學研究領域的大量投資、基因和細胞療法需求的不斷成長、疫苗研發的進步以及功能基因組學計劃的擴展等因素驅動，而所有這些都需要高效的核酸遞送技術。

市場概覽
預測期 2026-2030
市場規模：2024年 30.3億美元
市場規模：2030年 52.5億美元
複合年成長率：2025-2030年 9.61%
成長最快的細分市場 脂質體
最大的市場 北美洲

主要市場促進因素

全球轉染技術市場主要受兩大關鍵因素影響：一是細胞和基因療法需求的不斷成長，二是轉染方法和遞送系統的持續技術進步。不斷擴展的細胞和基因療法研發管線直接需要強大且高效的核酸遞送工具，這對於這些先進治療產品的研發和最終商業化至關重要。

主要市場挑戰

阻礙市場擴張的一大挑戰源自於某些轉染方法固有的細胞毒性和效率差異。這些問題直接影響細胞活力和檢測的可重複性，導致實驗失敗率上升、研發週期延長，以及昂貴試劑和人力的大量浪費。

主要市場趨勢

與先進基因編輯技術的整合代表了轉染技術的重大革新，它超越了單純的遺傳物質導入，實現了細胞內精準靶向的基因組修飾。透過轉染方法有效地遞送CRISPR-Cas系統等先進基因編輯工具，對於加速新型治療應用和功能基因組學的研究至關重要。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球轉染技術市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 透過轉染方法（共轉染、電穿孔、陽離子脂質體轉染、脂質體轉染、核轉染、體內轉染）
    • 依產品分類（試劑、儀器、其他）
    • 依應用領域（病毒生產、蛋白質生產、基因沉默、幹細胞重編程和分化、穩定細胞株建構、治療藥物傳遞、生物醫學研究、其他）
    • 依技術分類（物理轉染、生化轉染、病毒載體轉染）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美轉染技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲轉染技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區轉染技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲轉染技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲轉染技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球轉染技術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Roche Molecular Systems, Inc.
  • QIAGEN NV
  • Inovio Pharmaceuticals
  • Mirus Bio LLC
  • Takara Bio Inc.
  • SignaGen Laboratories
  • MaxCyte, Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23801

The Global Transfection Technologies Market, valued at USD 3.03 Billion in 2024, is projected to experience a CAGR of 9.61% to reach USD 5.25 Billion by 2030. Transfection technologies encompass methods for introducing exogenous nucleic acids, such as DNA or RNA, into eukaryotic cells, enabling genetic modification for various research, therapeutic, and bioproduction applications. The market's growth is primarily driven by substantial global investments in life sciences research, escalating demand for gene and cell therapies, advancements in vaccine development, and expanding functional genomics initiatives, all requiring efficient nucleic acid delivery.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.03 Billion
Market Size 2030USD 5.25 Billion
CAGR 2025-20309.61%
Fastest Growing SegmentLipofection
Largest MarketNorth America

Key Market Drivers

The Global Transfection Technologies Market is significantly influenced by two critical factors: the growing demand for cell and gene therapies and continuous technological advancements in transfection methods and delivery systems. The expanding pipeline of cell and gene therapies directly necessitates robust and efficient nucleic acid delivery tools, crucial for the research, development, and eventual commercialization of these advanced therapeutic products.

Key Market Challenges

A significant challenge impeding market expansion stems from the inherent cytotoxicity and variable efficiency associated with certain transfection methods. These issues directly compromise cell viability and assay reproducibility, leading to increased experimental failures, extended research and development timelines, and substantial wastage of costly reagents and labor. Compromised cell viability necessitates repeated experiments, driving up operational expenditures for biopharmaceutical companies engaged in drug discovery and therapeutic development. Similarly, inconsistent transfection efficiency results in unreliable data, requiring extensive validation and re-evaluation, thereby slowing the progression of promising candidates from preclinical stages to clinical trials.

Key Market Trends

The integration with advanced gene editing technologies represents a pivotal evolution in transfection, moving beyond mere genetic material introduction to enabling precise and targeted genomic modifications within cells. The effective delivery of advanced gene editing tools, such as CRISPR-Cas systems, by transfection methods is instrumental in accelerating research for novel therapeutic applications and functional genomics. This integration facilitates the correction of specific disease-causing mutations and precise modulation of gene expression. The expanded utility in these highly targeted applications amplifies the demand for sophisticated delivery systems that ensure high efficiency, cell viability, and minimal off-target effects.

Key Market Players

  • Promega Corporation
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Roche Molecular Systems, Inc.
  • QIAGEN NV
  • Inovio Pharmaceuticals
  • Mirus Bio LLC
  • Takara Bio Inc.
  • SignaGen Laboratories
  • MaxCyte, Inc.

Report Scope:

In this report, the Global Transfection Technologies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Transfection Technologies Market, By Transfection Method:

  • Cotransfection
  • Electroporation
  • Cationic Lipid Transfection
  • Lipofection
  • Nucleofection
  • In Vivo Transfection

Transfection Technologies Market, By Product:

  • Reagent
  • Instrument
  • Others

Transfection Technologies Market, By Application:

  • Virus Production
  • Protein Production
  • Gene Silencing
  • Stem Cell Reprogramming and Differentiation
  • Stable Cell Line Generation
  • Therapeutic Delivery
  • Bio-Medical Research
  • Others

Transfection Technologies Market, By Technology:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Transfection Technologies Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Transfection Technologies Market.

Available Customizations:

Global Transfection Technologies Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Transfection Technologies Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Transfection Method (Cotransfection, Electroporation, Cationic Lipid Transfection, Lipofection, Nucleofection, In Vivo Transfection)
    • 5.2.2. By Product (Reagent, Instrument, Others)
    • 5.2.3. By Application (Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming and Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Bio-Medical Research, Others)
    • 5.2.4. By Technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Transfection Technologies Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Transfection Method
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By Technology
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Transfection Technologies Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Transfection Method
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Technology
    • 6.3.2. Canada Transfection Technologies Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Transfection Method
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Technology
    • 6.3.3. Mexico Transfection Technologies Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Transfection Method
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Technology

7. Europe Transfection Technologies Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Transfection Method
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By Technology
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Transfection Technologies Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Transfection Method
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Technology
    • 7.3.2. France Transfection Technologies Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Transfection Method
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Technology
    • 7.3.3. United Kingdom Transfection Technologies Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Transfection Method
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Technology
    • 7.3.4. Italy Transfection Technologies Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Transfection Method
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Technology
    • 7.3.5. Spain Transfection Technologies Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Transfection Method
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Technology

8. Asia Pacific Transfection Technologies Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Transfection Method
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Technology
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Transfection Technologies Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Transfection Method
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Technology
    • 8.3.2. India Transfection Technologies Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Transfection Method
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Technology
    • 8.3.3. Japan Transfection Technologies Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Transfection Method
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Technology
    • 8.3.4. South Korea Transfection Technologies Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Transfection Method
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Technology
    • 8.3.5. Australia Transfection Technologies Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Transfection Method
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Technology

9. Middle East & Africa Transfection Technologies Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Transfection Method
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By Technology
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Transfection Technologies Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Transfection Method
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Technology
    • 9.3.2. UAE Transfection Technologies Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Transfection Method
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Technology
    • 9.3.3. South Africa Transfection Technologies Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Transfection Method
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Technology

10. South America Transfection Technologies Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Transfection Method
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Technology
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Transfection Technologies Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Transfection Method
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Technology
    • 10.3.2. Colombia Transfection Technologies Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Transfection Method
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Technology
    • 10.3.3. Argentina Transfection Technologies Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Transfection Method
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Technology

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Transfection Technologies Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Promega Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Bio-Rad Laboratories, Inc.
  • 15.4. Roche Molecular Systems, Inc.
  • 15.5. QIAGEN NV
  • 15.6. Inovio Pharmaceuticals
  • 15.7. Mirus Bio LLC
  • 15.8. Takara Bio Inc.
  • 15.9. SignaGen Laboratories
  • 15.10. MaxCyte, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer